//
Cardiac Implantable Electronic Devices in Patients With Left Ventricular Assist Systems
The Management of Atrial Fibrillation in Heart Failure: An Expert Panel Consensus
Positive recommendation for angiotensin receptor/neprilysin inhibitor: First medication approval for heart failure without "reduced ejection fraction"
Dapagliflozin for treating chronic heart failure with reduced ejection fraction
Myofibroblast Phenotype and Reversibility of Fibrosis in Patients With End-Stage Heart Failure
Association of Reduced Apical Untwisting With Incident HF in Asymptomatic Patients With HF Risk Factors
Ranolazine in High-Risk Patients With Implanted Cardioverter-Defibrillators - The RAID Trial
INTERMACS Profiles and Outcomes Among Non–Inotrope-Dependent Outpatients With Heart Failure and Reduced Ejection Fraction